Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Numinus Wellness Focused on Boosting Profitability and Expanding Community Support (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News ARCA Biopharma Inc ABIO

Healthcare Biotechnology
ARCA biopharma, Inc. is a clinical-stage biopharmaceutical company engaged in developing genetically and other targeted therapies for cardiovascular diseases through a precision medicine approach to drug development. The Company's lead product candidate is Gencaro (bucindolol hydrochloride) for the treatment of atrial fibrillation (AF) in patients with chronic heart failure (HF). Gencaro is... see more

Recent & Breaking News (NDAQ:ABIO)

ARCA Biopharma Announces Third Quarter 2019 Financial Results and Provides Corporate Update

GlobeNewswire November 6, 2019

ARCA Biopharma President and CEO Dr. Michael Bristow to Present at HFSA 2019 Excellence in Translational Science Symposium

GlobeNewswire September 12, 2019

Arca Biopharma Announces Gencaro Atrial Fibrillation Clinical Data Selected for Presentation at HFSA 2019 Scientific Meeting

GlobeNewswire September 11, 2019

INVESTOR ACTION NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Abiomed, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

GlobeNewswire August 21, 2019

ARCA biopharma Announces Second Quarter 2019 Financial Results and Provides Corporate Update

GlobeNewswire August 1, 2019

ARCA biopharma Announces Submission of Patent Application to U.S. Patent and Trademark Office Covering Treatment of Atrial Fibrillation in Patients With Heart Failure

GlobeNewswire May 13, 2019

ARCA Biopharma Announces First Quarter 2019 Financial Results and Provides Corporate Update

GlobeNewswire May 8, 2019

GENETIC-AF Phase 2B Trial Results Published in the Journal of American College of Cardiology: Heart Failure

GlobeNewswire May 1, 2019

ARCA biopharma Announces Steering Committee of Leading International Cardiology and Electrophysiology Experts for PRECISION-AF Phase 3 Clinical Trial

GlobeNewswire April 23, 2019

Identification of Phosphodiesterease 3A Polymorphism With Potential to Increase Effectiveness of PDE3 Inhibitors Published in the Journal of the American College of Cardiology

GlobeNewswire March 18, 2019

Dose Response of Beta-Blockers in Adrenergic Receptor Polymorphism Genotypes Paper Published in Circulation: Genomic and Precision Medicine

GlobeNewswire March 6, 2019

ARCA biopharma Announces Fiscal Year 2018 Financial Results and Provides Corporate Update

GlobeNewswire February 27, 2019

Thinking about buying stock in ARCA biopharma, Clearside Biomedical, Kandi Technologies, Nike or Tahoe Resources?

PR Newswire February 21, 2019

75 Biggest Movers From Yesterday

Benzinga.com  February 21, 2019

Mid-Afternoon Market Update: Crude Oil Up 1.5%; Kandi Technologies Shares Spike Higher

Benzinga.com  February 20, 2019

54 Stocks Moving In Wednesday's Mid-Day Session

Benzinga.com  February 20, 2019

Mid-Day Market Update: LeMaitre Vascular Surges Following Strong Q4 Results; Sienna Biopharmaceuticals Shares Slide

Benzinga.com  February 20, 2019

Mid-Morning Market Update: Markets Mostly Flat; CVS Health Issues Weak Earnings Outlook

Benzinga.com  February 20, 2019

ARCA Biopharma Announces FDA Agreement for a Single Phase 3 Clinical Trial to Support Approval for the First Genetically-Targeted Cardiovascular Drug

GlobeNewswire February 20, 2019

Zosano Appoints Linda Grais M.D., J.D. to Board of Directors

GlobeNewswire January 16, 2019